Sales and Marketing

Showing 15 posts of 11527 posts found.

Reuters chief executive joins Pfizer board

July 2, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, james smith, reuters

Pfizer has appointed the chief executive of information and media giant Thomson Reuters to its board of directors. James Smith …

Doctors who miss cancer to be named and shamed

July 1, 2014 Sales and Marketing Cancer, GPs, Hunt, NHS, UK, doctors, oncology

In a new government initiative doctors who consistently fail to diagnose signs of cancer could be publically named on an …

Astellas names Americas head

July 1, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Tatjana Dragovic, americas

Astellas has appointed Tatjana Dragovic as its VP and regional compliance officer for the firm’s Americas region. In this role …

Government gets £74m rebate from pharma

June 30, 2014 Sales and Marketing ABPI, Hunt, NHS, PPRS, VBP, emms, pricing

The UK government has received a £74 million refund from the pharma industry after it was deemed to have spent …

FDA ‘yes’ to inhaled insulin

June 30, 2014 Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human

The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …

GSK China sex tape ‘sent to Witty’

June 30, 2014 Medical Communications, Research and Development, Sales and Marketing China, GSK, Mark Reilly, Witty, corruption, sex tape

GlaxoSmithKline was scrambling to defend itself over the weekend as new details emerged concerning the extent of its suspected corruption …

CHMP approves six drugs including daclatasvir

June 30, 2014 Sales and Marketing BMS, CHMP, HCV, Plavix, daclatasvir, daklinza, ge

A key advisory committee for the European Medicines Agency has given its approval to six new drugs at its latest …

Quantum Pharmaceutical adds head of commercial

June 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brown, quantum pharma

UK medicines supplier and manufacturing firm Quantum Pharmaceutical has expanded its team with the appointment of a new head of …

Value tops the agenda at ASCO cancer conference

June 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, Cancer, chicago, mccafferty, oncology

The annual American Society of Clinical Oncology (ASCO) meeting has long been one of the most important events on the …

NICE U-turn on cancer drug despite price increase

June 27, 2014 Sales and Marketing Cancer, Glivec, NHS, Novartis, gists

UK pricing watchdog NICE has performed a U-turn on Glivec (imatinib) by issuing new draft guidance recommending the drug, despite …

FDA rejects olaparib

June 27, 2014 Sales and Marketing AstraZeneca, Cancer, FDA, PARP, adp, olaparib

AstraZeneca has been dealt a blow by a key advisory committee to the US Food and Drug Administration, which has …

Ranbaxy’s Diovan copycat approved in US

June 27, 2014 Manufacturing and Production, Sales and Marketing Diovan, FDA, Novartis, Ranbaxy, blood pressure, sun pharmaceuticals, valsartan

Ranbaxy has won approval for its copycat form of Novartis’ blockbuster blood pressure drug Diovan, as the Swiss firm finally …

BMS expands data transparency

June 27, 2014 Medical Communications, Sales and Marketing BMS, best electronic cigarettes, csr, dcri, transparency

Bristol-Myers Squibb is to expand access to its clinical trial data – but researchers’ requests will have to be approved …

Biotec names commercial director

June 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, martin lamb

Clinical trials services firm Biotec Services International has appointed Martin Lamb to the position of commercial director. Lamb will lead …

NICE recommends tenth diabetes drug

June 26, 2014 Sales and Marketing Janssen, NHS, diabetes, invokana, type 2

In final guidance NICE has recommended Janssen’s Invokana as a treatment to help lower blood sugar levels in people with …
The Gateway to Local Adoption Series

Latest content